DEVELOPMENT OF THE RXR AGONIST IRX4204 TO TREAT MULTIPLE SCLEROSIS AND OTHER IMMUNE RELATED DISEASES

Project Number

5R44AI112512-03

Agency/Funding Organization

NIAID

Funding Year

2017

View Full Project Details